These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 2864260

  • 1. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR, Mueller RA.
    Eur J Pharmacol; 1985 Jul 11; 113(1):109-14. PubMed ID: 2864260
    [Abstract] [Full Text] [Related]

  • 2. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug 11; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 11; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM, Mohell N, Bengtsson A, Malmberg A.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):137-44. PubMed ID: 7498268
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR, Eliassi A.
    Gen Pharmacol; 1991 Aug 25; 22(6):1027-31. PubMed ID: 1687393
    [Abstract] [Full Text] [Related]

  • 9. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB, Jackson DM, Wallis EM, Edwards SR.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May 11; 337(5):512-8. PubMed ID: 3261844
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR, Criswell HE, McQuade RD, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1990 Feb 11; 252(2):558-67. PubMed ID: 1968972
    [Abstract] [Full Text] [Related]

  • 12. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS, Starr BS.
    Pharmacol Biochem Behav; 1989 May 11; 33(1):41-4. PubMed ID: 2571171
    [Abstract] [Full Text] [Related]

  • 13. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ.
    Pharmacol Biochem Behav; 1988 May 11; 30(1):189-93. PubMed ID: 2902644
    [Abstract] [Full Text] [Related]

  • 14. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 10; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.